Signaling molecules in nonfamilial pulmonary hypertension.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  New England Journal of Medicine

• Publication date

  2003-02-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1056/NEJMOA021650PMID 12571257
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differential expression of Tie-2 receptors and angiopoietins in response to in vivo hypoxia in rats.

  2001cited by this paper
• Human angiopoietin gene expression is a marker for severity of pulmonary hypertension in patients undergoing pulmonary thromboendarterectomy.

  2001cited by this paper
• BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension.

  2001cited by this paper
• Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia.

  2001cited by this paper
• Mutation in the gene for bone morphogenetic protein receptor II as a cause of primary pulmonary hypertension in a large kindred.

  2001cited by this paper
• Bone morphogenetic protein receptor complexes on the surface of live cells: a new oligomerization mode for serine/threonine kinase receptors.

  2000cited by this paper
• Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-β family

  2000cited by this paper
• Negative regulation of BMP/Smad signaling by Tob in osteoblasts.

  2000cited by this paper
• Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene.

  2000cited by this paper
• BMP2-induced Apoptosis Is Mediated by Activation of the TAK1-p38 Kinase Pathway That Is Negatively Regulated by Smad6*

  2000cited by this paper
• Heterozygous germline mutations in BMPR2, encoding a TGF-β receptor, cause familial primary pulmonary hypertension

  2000cited by this paper
• Early expression of angiogenesis factors in acute myocardial ischemia and infarction.

  2000cited by this paper
• Pulmonary endarterectomy.

  2000cited by this paper
• Identification of Tek/Tie2 Binding Partners

  1999cited by this paper
• Direct actions of angiopoietin-1 on human endothelium: evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors.

  1999cited by this paper
• Angiopoietin-1 induces sprouting angiogenesis in vitro.

  1998cited by this paper
• TGF-beta signalling from cell membrane to nucleus through SMAD proteins.

  1997cited by this paper
• Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis.

  1997cited by this paper
• TGF-β signalling from cell membrane to nucleus through SMAD proteins

  1997cited by this paper
• Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning.

  1996cited by this paper
• Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis.

  1996cited by this paper
• Blood vessel formation: what is its molecular basis?

  1996cited by this paper
• Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation

  1995cited by this paper
• Pathology and pathophysiology of primary pulmonary hypertension.

  1995cited by this paper
• Vascularization of the mouse embryo: A study of flk‐1, tek, tie, and vascular endothelial growth factor expression during development

  1995cited by this paper
• Histopathology of primary pulmonary hypertension. A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry.

  1989cited by this paper
• The Pathology of Hypertensive Pulmonary Vascular Disease: A Description of Six Grades of Structural Changes in the Pulmonary Arteries with Special Reference to Congenital Cardiac Septal Defects

  1958cited by this paper

• Deciphering the Counterintuitive Role of Vascular Endothelial Growth Factor Signaling Pathways in Pulmonary Arterial Hypertension

  2026cites this paper
• The NOTCH3 extracellular domain is a serum biomarker for pulmonary arterial hypertension

  2026cites this paper
• Loss of ALK3 Ameliorates Acute but Aggravates Chronic Lung Inflammation In Vivo

  2025cites this paper
• Why Is Pulmonary Endarterectomy Underused in Japan? Epidemiology, Genetics, and a Practical Operability Framework

  2025cites this paper
• LncRNA MYOSLID contributes to PH via targeting BMPR2 signaling in pulmonary artery smooth muscle cell.

  2024cites this paper
• The Effects of Obstructive Sleep Apnea on the Cardiovascular System: A Comprehensive Review

  2024cites this paper
• Exploring the pathogenesis of pulmonary vascular disease

  2024cites this paper
• Defective mesenchymal Bmpr1a-mediated BMP signaling causes congenital pulmonary cysts

  2024cites this paper
• The future of group 2 pulmonary hypertension: Exploring clinical trials and therapeutic targets.

  2023cites this paper
• Genetische Diagnostik und molekulare Ansätze bei pulmonalarterieller Hypertonie

  2023cites this paper
• Defective mesenchymal Bmpr1a-mediated BMP signaling causes congenital pulmonary cysts

  2023cites this paper
• Pulmonary Hypertension in Adults with Congenital Heart Disease.

  2022cites this paper
• BMPR1A Promotes ID2-ZEB1 Interaction to Suppress Excessive Endothelial to Mesenchymal Transition.

  2022cites this paper
• Compensatory roles of Protein Related to DAN and Cerberus (PRDC) decrease in pulmonary arterial hypertension

  2022cites this paper
• Bmpr2 mutant mice are an inadequate model for studying iron deficiency in pulmonary hypertension

  2022cites this paper
• Genes in pediatric pulmonary arterial hypertension and the most promising BMPR2 gene therapy

  2022cites this paper
• Sitting in class

  2022cites this paper
• miR-19a-3p Facilitates Lung Adenocarcinoma Cell Phenotypes by Inhibiting TEK

  2021cites this paper
• iPSC–endothelial cell phenotypic drug screening and in silico analyses identify tyrphostin-AG1296 for pulmonary arterial hypertension

  2021influential citation
• Endothelial Upregulation of Mechanosensitive Channel Piezo1 in Pulmonary Hypertension.

  2021cites this paper
• of the safety and efficacy of selexipag on morbidity and mortality in patients

  2021cites this paper
• Pulmonary Arterial Hypertension

  2021cites this paper
• Targeting the Angiopoietin/Tie Pathway: Prospects for Treatment of Retinal and Respiratory Disorders

  2021cites this paper
• Transitioning from Preclinical to Clinical Heart Failure with Preserved Ejection Fraction: A Mechanistic Approach

  2020cites this paper
• TEK Suppresses Lung Adenocarcinoma Cell Phenotypes by Interacting with miR-19a-3p

  2020cites this paper
• Pluripotent HSCs Augment a-Adrenergic Receptor-Mediated Contraction of Pulmonary Artery and Contribute to the Pathogenesis of Pulmonary Hypertension.

  2020cites this paper
• The Role and Regulation of Pulmonary Artery Smooth Muscle Cells in Pulmonary Hypertension

  2020cites this paper
• Beyond Thrombosis: the Role of Platelets in Pulmonary Hypertension

  2020cites this paper
• ‘There and Back Again’—Forward Genetics and Reverse Phenotyping in Pulmonary Arterial Hypertension

  2020cites this paper
• Targeting transforming growth factor-β receptors in pulmonary hypertension

  2020cites this paper
• Pluripotent hematopoietic stem cells augment (cid:2) -adrenergic receptor-mediated contraction of pulmonary artery and contribute to the pathogenesis of pulmonary hypertension

  2020cites this paper
• Tek (Tie2) is not required for cardiovascular development in zebrafish

  2020cites this paper
• Vital Roles of Gremlin‐1 in Pulmonary Arterial Hypertension Induced by Systemic‐to‐Pulmonary Shunts

  2020cites this paper
• Finding relationships among biological entities

  2020cites this paper
• Gene and protein-based therapies for improving cardiac performance and regeneration

  2020cites this paper
• The Biological Bases of Group 2 Pulmonary Hypertension

  2019cites this paper
• Evolution, From the Beginning

  2019cites this paper
• Epidemiology and pathophysiology

  2019cites this paper
• Therapeutic effects of the selective farnesoid X receptor agonist obeticholic acid in a monocrotaline-induced pulmonary hypertension rat model

  2019cites this paper
• DAN plays important compensatory roles in systemic‐to‐pulmonary shunt associated pulmonary arterial hypertension

  2019influential citation
• The Role of ID3 and PCB153 in the Hyperproliferation and Dysregulation of Lung Endothelial Cells

  2018influential citation
• A novel piperidine identified by stem cell-based screening attenuates pulmonary arterial hypertension by regulating BMP2 and PTGS2 levels

  2018cites this paper
• Drug abuse and HIV-related pulmonary hypertension: double hit injury

  2018cites this paper
• Germline BMP9 mutation causes idiopathic pulmonary arterial hypertension

  2018cites this paper
• New targets for pulmonary arterial hypertension: going beyond the currently targeted three pathways

  2017cites this paper
• Beneficial effects of bile acid receptor agonists in pulmonary disease models

  2017cites this paper
• Two-stage surgery for a large ventricular septal defect and patent ductus arteriosus associated with severe pulmonary arterial hypertension in an adult patient

  2017cites this paper
• Is it time to recognize a new phenotype? Heart failure with preserved ejection fraction with pulmonary vascular disease

  2017cites this paper
• Hyperoxia causes miR-34a-mediated injury via angiopoietin-1 in neonatal lungs

  2017cites this paper
• Cardiopulmonary protective effects of the selective FXR agonist obeticholic acid in the rat model of monocrotaline-induced pulmonary hypertension.

  2017cites this paper
• Restoring BMPRII functions in pulmonary arterial hypertension: opportunities, challenges and limitations

  2017influential citation
• VEGFR3 as a novel modulator for PAH

  2017cites this paper
• Pulmonary hypertension in patients without pulmonary arterial hypertension

  2016cites this paper
• Biomarkers in Lung Diseases : from Pathogenesis to Prediction to New Therapies Gene expression profile of angiogenic factors in pulmonary arteries in COPD : relationship with vascular remodeling

  2016cites this paper
• Loss of prolyl hydroxylase domain protein 2 in vascular endothelium increases pericyte coverage and promotes pulmonary arterial remodeling

  2016cites this paper
• Effect of Cocaine on Pulmonary Vascular Remodeling and Hemodynamics in Human Immunodeficiency Virus-Transgenic Rats.

  2016cites this paper
• Pulmonary Hypertension in Heart Failure Patients: Pathophysiology and Prognostic Implications

  2016cites this paper
• Biomarkers and Other Methods for Assessing Patient Progress

  2016cites this paper
• Circulating Angiopoietin-1 Is Not a Biomarker of Disease Severity or Prognosis in Pulmonary Hypertension

  2016cites this paper
• Gene expression profile of angiogenic factors in pulmonary arteries in COPD: relationship with vascular remodeling.

  2016cites this paper
• Lung Circulation.

  2016cites this paper
• Future perspectives in pulmonary arterial hypertension

  2016cites this paper
• Group 2 Pulmonary Hypertension: Pulmonary Venous Hypertension: Epidemiology and Pathophysiology.

  2016cites this paper
• Zukunftsperspektiven auf dem Gebiet der pulmonal-arteriellen Hypertonie

  2016cites this paper
• Epigenetic modulation as a therapeutic approach for pulmonary arterial hypertension

  2015cites this paper
• Insights Into the Pathobiology of Pulmonary Hypertension

  2015cites this paper
• Pulmonary Venous Hypertension

  2015cites this paper
• Serum endostatin is a genetically determined predictor of survival in pulmonary arterial hypertension.

  2015cites this paper
• Transforming growth factor-β superfamily in obstructive lung diseases. more suspects than TGF-β alone.

  2015cites this paper
• Pulmonary Hypertension in Obstructive Sleep Apnea: Is it Clinically Significant? a Critical Analysis of the Association and Pathophysiology

  2015influential citation
• Chronic thromboembolic pulmonary hypertension.

  2015cites this paper
• Lungs at high-altitude: genomic insights into hypoxic responses.

  2015cites this paper
• Pathogenic Mechanisms of Pulmonary Hypertension

  2015cites this paper
• Hypoxia inducible factor-1 mediates expression of miR-322: potential role in proliferation and migration of pulmonary arterial smooth muscle cells

  2015cites this paper
• Circulating Biomarkers in Pulmonary Arterial Hypertension

  2015cites this paper
• Significance of obstructive sleep apnea in the patient with pulmonary hypertension

  2015cites this paper
• The current approach into signaling pathways in pulmonary arterial hypertension and their implication in novel therapeutic strategies

  2014cites this paper
• Decreased apelin and apelin-receptor expression in the pulmonary vasculature of nitrofen-induced congenital diaphragmatic hernia

  2014cites this paper
• Role of epigenetics in pulmonary hypertension.

  2014cites this paper
• Pulmonary Hypertension in Congenital Heart Disease 121

  2014cites this paper
• Chronic thromboembolic pulmonary hypertension.

  2014cites this paper
• Proteasome inhibitor PS-341 attenuates flow-induced pulmonary arterial hypertension

  2014cites this paper
• Stimulation of cerebral angiogenesis by gene delivery.

  2014cites this paper
• Neutrophilic leukemoid reaction in a patient with high grade sarcoma.

  2014cites this paper
• Pathology, Pathobiology and Pathophysiology of Pulmonary Arterial Hypertension

  2014cites this paper
• Proteasome inhibitor PS-341 attenuates flow-induced pulmonary arterial hypertension

  2014cites this paper
• Molecular Mechanisms of Pulmonary Arterial Remodeling

  2014cites this paper
• Role of Epigenetics in Pulmonary Hypertension 1

  2014cites this paper
• Chronic thromboembolic pulmonary hypertension.

  2014cites this paper
• Chapter 39 – Treatment of Pulmonary Arterial Hypertension

  2013cites this paper
• Rodent models of group 1 pulmonary hypertension.

  2013cites this paper
• Diastolic pulmonary vascular pressure gradient: a predictor of prognosis in "out-of-proportion" pulmonary hypertension.

  2013cites this paper
• Obesity, the Metabolic Syndrome, and Pulmonary Hypertension

  2013cites this paper
• Yet to Come Reactive Oxygen Species in Pulmonary Vascular Remodeling Comprehensive Physiology Inflammation Shear stress Hypoxia Contractile phenotypic markers Proliferative phenotypic markers Altered Ca 2 + homeostasis Vascular SMC SMC contraction and proliferation Growth factors Pulmonary vascular

  2013cites this paper
• Downregulated bone morphogenetic protein signaling in nitrofen-induced congenital diaphragmatic hernia

  2013cites this paper
• Vascular remodeling in pulmonary hypertension

  2013cites this paper
• Reactive oxygen species in pulmonary vascular remodeling.

  2013cites this paper
• A Comprehensive Review: The Evolution of Animal Models in Pulmonary Hypertension Research; Are We there Yet?

  2013cites this paper
• Orchestral actions of angiopoietin-1 in vascular regeneration.

  2013cites this paper
• Survivin and Smac/DIABLO: role of apoptosis in experimental PAH

  2013cites this paper